Fibroblast-mediated collagen production and dermal extracellular matrix remodeling pathways (ECM remodeling pathways)

Fibroblast-mediated collagen production and dermal extracellular matrix (ECM) remodeling pathways encompass the complex biochemical processes by which dermal fibroblasts synthesize, organize, and degrade structural proteins like collagen and elastin. These pathways are primarily governed by the Transforming Growth Factor-beta (TGF-β) signaling cascade, which activates fibroblasts to transition into myofibroblasts, increasing the expression of Type I and Type III collagen (Source: PMID: 29155471). Concurrently, Matrix Metalloproteinases (MMPs) and their inhibitors (TIMPs) regulate the turnover of the ECM to maintain structural integrity and facilitate wound healing (Source: PMID: 24575169). In pathological states, overactivation of these pathways leads to fibrotic disorders such as systemic sclerosis or hypertrophic scarring, while their decline is a hallmark of skin aging and impaired wound repair (Source: NIH - StatPearls). Pharmacological modulation includes the use of retinoids to stimulate collagen synthesis or TGF-β inhibitors and pirfenidone to reduce excessive fibrosis (Source: PubChem). Understanding these pathways is critical for developing treatments for both dermatological conditions and systemic fibrotic diseases.

Other names

Dermal ECM remodelingFibroblast collagen synthesis pathwayDermal fibroblast activationConnective tissue remodelingECM homeostasis

Modulation of fibroblast activation via TGF-beta signaling inhibition, stimulation of collagen gene expression through retinoic acid receptors, or enzymatic degradation of collagen fibers.